Fieldcure
Seoul, KR · 1 known investors
Find your way into Fieldcure
Sign up to see every warm intro you have to Fieldcure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fieldcure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FieldCure develops iMET, an electric field-based cancer therapy device that applies alternating electric fields at specific frequencies to disrupt mitosis in cancer cells while sparing normal cells. The system includes 64-channel electrode control and an AI-based treatment planning system for patient-specific optimization, targeting intractable cancers such as pancreatic cancer.
Founders & leadership
MY
Myung-Geun YoonCEO
Investors · 1
Frequently asked questions
- What does Fieldcure do?
- FieldCure develops iMET, an electric field-based cancer therapy device that applies alternating electric fields at specific frequencies to disrupt mitosis in cancer cells while sparing normal cells. The system includes 64-channel electrode control and an AI-based treatment planning system for patient-specific optimization, targeting intractable cancers such as pancreatic cancer.
- Who founded Fieldcure?
- Fieldcure was founded by Myung-Geun Yoon.
- Who are Fieldcure's investors?
- Fieldcure's investors include Aju IB Investment.
- Where is Fieldcure headquartered?
- Fieldcure is headquartered in Seoul, KR.